<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39368246</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5150</ISSN><JournalIssue CitedMedium="Internet"><Volume>161</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Pediatric neurology</Title><ISOAbbreviation>Pediatr Neurol</ISOAbbreviation></Journal><ArticleTitle>Rate of Autoimmune Encephalitis in Children With First-Episode Psychosis.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>116</EndPage><MedlinePgn>113-116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pediatrneurol.2024.09.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0887-8994(24)00335-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Autoimmune encephalitis (AE) can present as first-episode psychosis (FEP) in children. An FEP diagnostic algorithm has been proposed, but how this algorithm applies to children is unknown. We assess the FEP diagnostic algorithm in children with FEP.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The FEP algorithm was applied to a retrospective cohort of children with FEP without other neurological symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four patients were included, with five AE (anti-N-methyl-d-aspartate receptor encephalitis) and 19 non-AE patients (12 primary psychiatric, two headaches, mycoplasma-related encephalitis, post-coronavirus disease 2019 encephalitis, drug reaction with eosinophilia and systemic symptoms [DRESS] syndrome, cobalamin C deficiency, and two unknown). Some non-AE patients (five of 19 = 26%) received immunotherapies, with symptom resolution in one of five (20%) with immunotherapy and in four of 14 (29%) without immunotherapy. The FEP algorithm recommended cerebrospinal fluid (CSF) testing in all (five of five = 100%) patients with AE and in six of 19 (32%) non-AE patients, resulting in 100% sensitivity (95% confidence interval [CI]: 100% to 100%) and 45.5% specificity (95% CI: 16% to 75%), with a negative predictive value of 100% (95% CI: 100% to 100%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FEP can occur in children from different causes, including AE and metabolic conditions. Evaluation of FEP should be broad, especially without CSF evidence of inflammation. The FEP algorithm is useful to assess patients who would benefit from CSF testing and should be assessed in larger cohorts.</AbstractText><CopyrightInformation>Copyright © 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Treiman</LastName><ForeName>Geffen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackwell</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, Department of Pediatrics, Emory University School of Medicine; Department of Pediatric Neuropsychology, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howarth</LastName><ForeName>Robyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, Department of Pediatrics, Emory University School of Medicine; Department of Pediatric Neuropsychology, Children's Healthcare of Atlanta, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gombolay</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, Department of Pediatrics, Emory University School of Medicine; Department of Pediatric Neurology, Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: ggombol@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR002381</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Neurol</MedlineTA><NlmUniqueID>8508183</NlmUniqueID><ISSNLinking>0887-8994</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-NMDAR encephalitis</Keyword><Keyword MajorTopicYN="N">Autoimmune encephalitis</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Psychosis</Keyword></KeywordList><CoiStatement>Declaration of competing interest G.T., L.B., and R.H. have nothing to declare. G.G. receives part time salary support from the Centers for Disease Control and Prevention for acute flaccid myelitis surveillance and an honorarium as a Media Editor for Pediatric Neurology, but this is not relevant to this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368246</ArticleId><ArticleId IdType="doi">10.1016/j.pediatrneurol.2024.09.011</ArticleId><ArticleId IdType="pii">S0887-8994(24)00335-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>